Filip Marcel Vanhoutte

Title: Filip Marcel Vanhoutte: Innovator in Pharmaceutical Compositions

Introduction

Filip Marcel Vanhoutte is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for inhalation therapies. His work is characterized by a focus on crystalline forms of compounds that enhance the efficacy of medications.

Latest Patents

Vanhoutte holds a patent for a compound titled "Crystalline 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamide." This invention provides inter alia a solid crystalline hydrate and an anhydrous form of the compound. Additionally, it includes dry powder pharmaceutical compositions for inhalation that utilize these solid crystalline forms. Vanhoutte's patent represents a significant advancement in the formulation of inhalable medications.

Career Highlights

Vanhoutte is currently associated with Respivert Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new therapeutic options for patients requiring inhalation treatments. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Throughout his career, Vanhoutte has collaborated with several professionals, including Patrick Hubert J Nieste and Alex Herman Copmans. These collaborations have fostered a productive environment for innovation and have contributed to the success of his projects.

Conclusion

Filip Marcel Vanhoutte is a distinguished inventor whose work in pharmaceutical compositions has the potential to improve inhalation therapies significantly. His contributions to the field are marked by a commitment to innovation and collaboration.